|
US5268454A
(en)
*
|
1991-02-08 |
1993-12-07 |
La Jolla Pharmaceutical Company |
Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
|
|
KR100361933B1
(ko)
*
|
1993-09-08 |
2003-02-14 |
라 졸라 파마슈티칼 컴파니 |
화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
|
|
US5874409A
(en)
|
1995-06-07 |
1999-02-23 |
La Jolla Pharmaceutical Company |
APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
|
|
US6410775B1
(en)
*
|
1995-06-07 |
2002-06-25 |
La Jolla Pharmaceutical Company |
APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
|
|
US5817752A
(en)
*
|
1996-06-06 |
1998-10-06 |
La Jolla Pharmaceutical Company |
Cyclic polypeptides comprising a thioether linkage and methods for their preparation
|
|
KR20000016414A
(ko)
*
|
1996-06-06 |
2000-03-25 |
와이즈먼 앤드루 |
Apl 면역반응성 펩티드, 그것의 콘주게이트 및 apl항체-매개병변의 치료방법
|
|
US6812327B1
(en)
|
1996-10-25 |
2004-11-02 |
Human Genome Sciences, Inc. |
Neutrokine-alpha polypeptides
|
|
US8212004B2
(en)
*
|
1999-03-02 |
2012-07-03 |
Human Genome Sciences, Inc. |
Neutrokine-alpha fusion proteins
|
|
US6858210B1
(en)
|
1998-06-09 |
2005-02-22 |
La Jolla Pharmaceutical Co. |
Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
|
|
IL126447A
(en)
*
|
1998-10-04 |
2004-09-27 |
Vascular Biogenics Ltd |
An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
|
|
US20050197283A1
(en)
*
|
1998-10-04 |
2005-09-08 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
|
|
US6399578B1
(en)
*
|
1998-12-09 |
2002-06-04 |
La Jolla Pharmaceutical Company |
Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
|
|
US20010010818A1
(en)
*
|
1998-12-09 |
2001-08-02 |
Engle Steven B. |
Methods and formulations for reducing circulating antibodies
|
|
US6458953B1
(en)
|
1998-12-09 |
2002-10-01 |
La Jolla Pharmaceutical Company |
Valency platform molecules comprising carbamate linkages
|
|
CN1762990A
(zh)
*
|
1999-06-08 |
2006-04-26 |
拉卓拉药物公司 |
包含氨基氧基的化合价平台分子
|
|
AUPQ272699A0
(en)
*
|
1999-09-09 |
1999-09-30 |
Unisearch Limited |
Use of beta2GPI in diagnostic tests for autoimmune diseases
|
|
MXPA02005236A
(es)
*
|
1999-11-28 |
2004-03-19 |
Jolla Pharma |
Metodos de tratamiento de lupus con base en la afinidad de anticuerpos y metodos de separacion por exclusion y composiciones para el uso de los mismos.
|
|
JP2003531588A
(ja)
|
2000-04-11 |
2003-10-28 |
ジェネンテック・インコーポレーテッド |
多価抗体とその用途
|
|
WO2001093914A2
(en)
|
2000-06-08 |
2001-12-13 |
La Jolla Pharmaceutical Company |
Multivalent platform molecules comprising high molecular weight polyethylene oxide
|
|
US7879328B2
(en)
*
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
|
PT2281843T
(pt)
*
|
2000-06-16 |
2017-01-02 |
Human Genome Sciences Inc |
Anticorpos que se ligam imunoespecificamente a blys
|
|
AU2001288301A1
(en)
*
|
2000-08-18 |
2002-03-04 |
Human Genome Sciences, Inc. |
Binding polypeptides and methods based thereon
|
|
AU8506601A
(en)
*
|
2000-08-18 |
2002-03-04 |
Dyax Corp |
Binding polypeptides for b lymphocyte stimulator protein (blys)
|
|
US7319012B2
(en)
*
|
2001-05-30 |
2008-01-15 |
Gene Therapy Systems, Inc. |
Protein arrays and methods and systems for producing the same
|
|
EP2423335B1
(en)
|
2001-06-21 |
2014-05-14 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same
|
|
US20030114405A1
(en)
*
|
2001-08-13 |
2003-06-19 |
Linnik Matthew D. |
Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function
|
|
US7105135B2
(en)
*
|
2001-10-16 |
2006-09-12 |
Lockheed Martin Corporation |
System and method for large scale detection of hazardous materials in the mail or in other objects
|
|
DE60222816T2
(de)
*
|
2001-12-03 |
2008-07-03 |
Amgen Fremont Inc. |
Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
|
|
US7771951B2
(en)
*
|
2001-12-03 |
2010-08-10 |
Amgen Fremont Inc. |
Antibody categorization based on binding characteristics
|
|
CA2469196A1
(en)
*
|
2001-12-03 |
2003-06-12 |
Abgenix, Inc. |
Discovery of therapeutic products
|
|
AU2003237870A1
(en)
*
|
2002-06-07 |
2003-12-22 |
The Brigham & Women's Hospital, Inc. |
Method and composition for inhibing or slowing blood coagulation
|
|
CN100471486C
(zh)
|
2002-08-12 |
2009-03-25 |
戴纳伐克斯技术股份有限公司 |
免疫调节组合物,其制备方法和使用方法
|
|
WO2004060320A2
(en)
*
|
2002-12-27 |
2004-07-22 |
La Jolla Pharmaceutical Company |
Methods of improving health-related quality of life in individuals with systemic lupus erythematosus
|
|
US20040258683A1
(en)
*
|
2003-03-30 |
2004-12-23 |
Linnik Matthew D. |
Methods of treating and monitoring systemic lupus erythematosus in individuals
|
|
US7771956B2
(en)
*
|
2003-06-30 |
2010-08-10 |
Brigham & Women's Hospital, Inc. |
Method for detecting the presence of a phospholipid
|
|
US9062392B2
(en)
*
|
2003-12-30 |
2015-06-23 |
Intel Corporation |
Methods for isolating a peptide methods for identifying a peptide
|
|
JP2008514187A
(ja)
|
2004-09-01 |
2008-05-08 |
ダイナバックス テクノロジーズ コーポレイション |
先天性免疫応答及び自己免疫疾患の阻害法及び阻害用組成物
|
|
EP1799709B1
(en)
*
|
2004-09-30 |
2012-04-04 |
ORICO Limited |
Myostatin isoform
|
|
CN101146826A
(zh)
*
|
2005-01-24 |
2008-03-19 |
得克萨斯大学体系董事会 |
与磷脂酰丝氨酸结合的fc融合构建体及其治疗用途
|
|
EP1874334A4
(en)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
COMPOSITIONS WITH BETA 2-GLYCOPROTEIN I-PEPTIDES FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES
|
|
WO2007142667A2
(en)
*
|
2005-10-13 |
2007-12-13 |
Human Genome Sciences, Inc. |
Treatment of patients with autoantibody positive disease
|
|
US9168286B2
(en)
*
|
2005-10-13 |
2015-10-27 |
Human Genome Sciences, Inc. |
Methods and compositions for use in treatment of patients with autoantibody positive disease
|
|
WO2007123765A2
(en)
*
|
2006-03-31 |
2007-11-01 |
Human Genome Sciences Inc. |
Neutrokine-alpha and neutrokine-alpha splice variant
|
|
CN101522707B
(zh)
*
|
2006-08-03 |
2013-08-28 |
莫约斯汀医疗有限公司 |
肌肉生长抑制素拮抗剂
|
|
WO2009052148A1
(en)
*
|
2007-10-15 |
2009-04-23 |
California Institute Of Technology |
Functionalized polymers using protected thiols
|
|
EP2209896B1
(en)
|
2007-10-26 |
2017-03-01 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of immune responses and autoimmunity
|
|
WO2010093993A2
(en)
*
|
2009-02-12 |
2010-08-19 |
Human Genome Sciences, Inc. |
Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
|
|
EP2582398B1
(en)
|
2010-06-16 |
2016-04-13 |
Dynavax Technologies Corporation |
Methods of treatment using tlr7 and/or tlr9 inhibitors
|
|
US9228184B2
(en)
|
2012-09-29 |
2016-01-05 |
Dynavax Technologies Corporation |
Human toll-like receptor inhibitors and methods of use thereof
|
|
CN105353137A
(zh)
*
|
2015-12-10 |
2016-02-24 |
中国农业科学院饲料研究所 |
一种快速检测色素苏丹红的方法
|
|
JP7117741B2
(ja)
*
|
2018-10-10 |
2022-08-15 |
国立大学法人 鹿児島大学 |
ＩｇＧ結合性ペプチドを含む固相担体及びＩｇＧの分離方法
|
|
WO2022197295A1
(en)
*
|
2021-03-17 |
2022-09-22 |
Milliken & Company |
Polymeric colorants with reduced staining
|